Exzeo Group, Inc. disclosed a purchase by Chief Executive Officer Paresh Patel of 2,000 shares of common stock on April 16, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The shares were acquired at $16.76 each, bringing the total consideration for the trade to $33,520.
The transaction coincides with a short-term uptick in the company’s share price. XZO closed at $17.50 in recent trading, a level that represents a 10.42% increase over the preceding week. Publicly reported valuation metrics show a price-to-earnings ratio of 16.13 for the company and a price/earnings-to-growth ratio of 0.16.
After the April 16 purchase, Patel’s direct holdings in Exzeo total 1,616,013 shares. In addition to those shares, Patel is the holder of an option to purchase 5,000,000 shares of common stock. That option is exercisable from October 1, 2021, and its vesting schedule was structured so that one fourth of the option vested on October 1, 2022, with subsequent vesting occurring in one sixteenth increments on each January 1, April 1, July 1 and October 1 thereafter, as detailed in the filing.
Investors and market watchers have also received recent financial disclosures from Exzeo. The company reported fourth-quarter and full-year 2025 results that met consensus expectations. Reported diluted earnings per share for the period were $0.25, in line with analyst forecasts, while quarterly revenue came in at $53.32 million. The report was characterized as demonstrating steady performance over the reported period.
Market commentary included in the filing notes that valuation measures and recent share movement have attracted attention. The stated P/E of 16.13 and a PEG ratio of 0.16 were presented alongside the recent share-price appreciation. The filing also references analysis available through InvestingPro, which includes Fair Value estimates and Pro Research Reports for US equities, noting that additional research resources and ProTips are available to subscribers.
Analyst reaction to the earnings release was acknowledged but not specified. The filing indicated that some analyst firms have adjusted their outlooks in response to Exzeo’s financials, although no individual firms or the substance of those adjustments were named. The company’s financial statements and the insider transaction are part of ongoing disclosures that investors are monitoring for indications of the firm’s direction and financial health.
All transaction details, ownership figures and the option vesting schedule above are taken from the company’s SEC filing and the reported financial statements; no further commentary or forecasting on future performance was provided in the filing.
Context
This filing documents a direct purchase by the CEO, the existing significant equity stake and a large outstanding option grant with a multi-year vesting schedule. The company’s latest quarterly results met prevailing analyst expectations and showed quarterly revenue of $53.32 million alongside diluted EPS of $0.25.